Clinical Trial Update: Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary Sarcoidosis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating intravenous efzofitimod for pulmonary sarcoidosis, focusing on efficacy and safety results. The study is currently acti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Sarcoidosis

Drugs mentioned

• Efzofitimod (efzofitimod)

Snippet

Sponsor: aTyr Pharma, Inc. | Conditions: Pulmonary Sarcoidosis | Phase 3 | Status: ACTIVE_NOT_RECRUITING